Depletion of gut commensal bacteria attenuates intestinal ischemia/reperfusion injury
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Gut commensal bacteria play important roles in the development and homeostasis of intestinal immunity. However, the role of gut commensals in intestinal ischemia/reperfusion (I/R) injury is unclear. To determine the roles of gut commensal bacteria in intestinal IR injury, we depleted gut microbiota with a broad-spectrum antibiotic cocktail and performed mesenteric I/R (M I/R). First, we confirmed that antibiotic treatment completely depleted gut commensal bacteria and diminished the size of secondary lymphoid tissues such as the Peyer's patches. We next found that antibiotic treatment attenuated intestinal injury following M I/R. Depletion of gut commensal bacteria reduced the expression of Toll-like receptor (TLR)2 and TLR4 in the intestine. Both are well-known receptors for gram-positive and -negative bacteria. Decreased expression of TLR2 and TLR4 led to the reduction of inflammatory mediators, such as TNF, IL-6, and cyclooxygenase-2. Intestinal I/R injury is initiated when natural antibodies recognize neo-antigens that are revealed on ischemic cells and activate the complement pathway. Thus we evaluated complement and immunoglobulin (Ig) deposition in the damaged intestine and found that antibiotic treatment decreased the deposition of both C3 and IgM. Interestingly, we also found that the deposition of IgA also increased in the intestine following M I/R compared with control mice and that antibiotic treatment decreased the deposition of IgA in the damaged intestine. These results suggest that depletion of gut commensal bacteria decreases B cells, Igs, and TLR expression in the intestine, inhibits complement activation, and attenuates intestinal inflammation and injury following M I/R.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
DAMPs, PAMPs and alarmins: all we need to know about danger
Bianchi, M. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306164 · Cited by 2,794 · cited 1×
“However, recent studies have shown that TLRs can recognize nonmicrobial ligands, including danger-associated molecular patterns and other products of inflamed tissue (9, 35, 42).”
BackgroundA microbial symbiosis factor prevents intestinal inflammatory disease
Mazmanian, S. K., Round, J. L., & Kasper, D. L. (2008) · Nature · doi:10.1038/nature07008 · Cited by 2,340
Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach
Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., et al. (2006) · Gut · doi:10.1136/gut.2005.073817 · Cited by 2,277 · cited 2×
“Perturbations in the composition of gut microbiota in patients or animal models, known as dysbiosis, are associated with multiple diseases such as inflammatory bowel disease (IBD) (41), diabetes (66, 72), allergy (47), autoimmune diseases (6, 38, 68), and obesity (39), and dysbiosis can greatly influence the pathogene…”
BackgroundInnate immunity and intestinal microbiota in the development of Type 1 diabetes
Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C., Wong, F. S., Szot, G. L., Bluestone, J. A., et al. (2008) · Nature · doi:10.1038/nature07336 · Cited by 1,921 · cited 1×
“Perturbations in the composition of gut microbiota in patients or animal models, known as dysbiosis, are associated with multiple diseases such as inflammatory bowel disease (IBD) (41), diabetes (66, 72), allergy (47), autoimmune diseases (6, 38, 68), and obesity (39), and dysbiosis can greatly influence the pathogene…”
BackgroundGut-Residing Segmented Filamentous Bacteria Drive Autoimmune Arthritis via T Helper 17 Cells
Wu, H.-J., Ivanov, I. I., Darce, J., Hattori, K., Shima, T., Umesaki, Y., Littman, D. R., Benoist, C., & Mathis, D. (2010) · Immunity · doi:10.1016/j.immuni.2010.06.001 · Cited by 1,577
Sellon, R. K., Tonkonogy, S., Schultz, M., Dieleman, L. A., Grenther, W., Balish, E., Rennick, D. M., & Sartor, R. B. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5224-5231.1998 · Cited by 1,483
Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis
Lee, Y. K., Menezes, J. S., Umesaki, Y., & Mazmanian, S. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000082107 · Cited by 1,323 · cited 1×
“Perturbations in the composition of gut microbiota in patients or animal models, known as dysbiosis, are associated with multiple diseases such as inflammatory bowel disease (IBD) (41), diabetes (66, 72), allergy (47), autoimmune diseases (6, 38, 68), and obesity (39), and dysbiosis can greatly influence the pathogene…”
BackgroundAbreu, M. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2707 · Cited by 1,288 · cited 1×
“Innate immune responses against microorganisms are mediated by innate TLRs, nucleotide-binding oligomerization domain-like receptors, and G protein-coupled receptors (1, 10, 32).”
BackgroundLymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis
Bouskra, D., Brézillon, C., Bérard, M., Werts, C., Varona, R., Boneca, I. G., & Eberl, G. (2008) · Nature · doi:10.1038/nature07450 · Cited by 1,107
Penders, J., Thijs, C., van den Brandt, P. A., Kummeling, I., Snijders, B., Stelma, F., Adams, H., van Ree, R., & Stobberingh, E. E. (2007) · Gut · doi:10.1136/gut.2006.100164 · Cited by 844 · cited 2×
“Some inflammatory diseases have been reported to be clearly linked to certain gut bacteria or their factors (29, 43, 47, 68).”
BackgroundThe essential role of the intestinal microbiota in facilitating acute inflammatory responses
Souza, D. G., Vieira, A. T., Soares, A. C., Pinho, V., Nicoli, J. R., Vieira, L. Q., & Teixeira, M. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.4137 · Cited by 247 · cited 2×
“Germ-free mice were reported to have less local and remote injury following M I/R (59).”
BackgroundShimizu, K., Ogura, H., Hamasaki, T., Goto, M., Tasaki, O., Asahara, T., Nomoto, K., Morotomi, M., Matsushima, A., Kuwagata, Y., et al. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1418-8 · Cited by 213 · cited 1×
“Clinically, abnormal composition of gut flora has been considered to have major influences on the severity and prognosis of critically ill patients in acute states (18, 34, 55, 62).”
Background
Cited by
Cell Biology of Ischemia/Reperfusion Injury
(2012) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-394309-5.00006-7 · Cited by 2,178
Kalogeris, T., Baines, C. P., Krenz, M., & Korthuis, R. J. (2016) · Comprehensive Physiology · doi:10.1002/cphy.c160006 · Cited by 718
Kennedy, E. A., King, K. Y., & Baldridge, M. T. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01534 · Cited by 602
Brandt, L. J., Feuerstadt, P., Longstreth, G. F., & Boley, S. J. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.395 · Cited by 377
Yarandi, S. S., & Srinivasan, S. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12330 · Cited by 236
Metadata
- Authors
- Yoshiya, K., Lapchak, P. H., Thai, T.-H., Kannan, L., Rani, P., Lucca, J. J. D., & Tsokos, G. C.
- Venue
- American Journal of Physiology-Gastrointestinal and Liver Physiology
- Publisher
- American Physiological Society
- Published
- 2011-12
- Volume
- 301
- Issue
- 6
- Pages
- G1020-G1030
- ISSN
- 0193-1857 (ISSN-L)
- 1522-1547
- OpenAlex
- W2168699292
- Cited by
- 103
- References
- 13
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.